Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice
Authors:
- 1 April 1999
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 13 (6) , 667-675
Abstract
Antioxidants can inhibit atherosclerosis in animals, though it is not clear whether this is due to the inhibition of aortic lipoprotein lipid (per)oxidation. Coantioxidants inhibit radical‐induced, tocopherol‐mediated peroxidation of lipids in lipoproteins through elimination of tocopheroxyl radical. Here we tested the effect of the bisphenolic probucol metabolite and coantioxidant H 212/43 on atherogenesis in apolipoprotein E and low density lipoprotein (LDL) receptor gene double knockout (apoE‐/‐;LDLr‐/‐) mice, and how this related to aortic lipid (per)oxidation measured by specific HPLC analyses. Dietary supplementation with H 212/43 resulted in circulating drug levels of ∼200 µM, increased plasma total cholesterol slightly and decreased plasma and aortic α‐tocopherol significantly relative to age‐matched control mice. Treatment with H 212/43 increased the antioxidant capacity of plasma, as indicated by prolonged inhibition of peroxyl radical‐induced, ex vivo lipid peroxidation. Aortic tissue from control apoE‐/‐;LDLr‐/‐ mice contained lipid hydro(pero)xides and substantial atherosclerotic lesions, both of which were decreased strongly by supplementation of the animals with H 212/43. The results show that a coantioxidant effectively inhibits in vivo lipid peroxidation and atherosclerosis in apoE‐/‐;LDLr‐/‐ mice, consistent with though not proving a causal relationship between aortic lipoprotein lipid oxidation and atherosclerosis in this model of the disease.—Witting, P. K., Pettersson, K., Östlund‐Lindqvist, A.‐M., Westerlund, C., Westin Eriksson, A., Stocker, R. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J. 13, 667–675 (1999)Keywords
Funding Information
- National Health and Medical Research Council (970998)
This publication has 45 references indexed in Scilit:
- Stimulation of Gsand Inhibition of GiProtein Functions by Minimally Oxidized LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and AscorbateArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Lipids and oxidised lipids in human atherosclerotic lesions at different stages of developmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbitsAtherosclerosis, 1992
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992
- Beyond CholesterolNew England Journal of Medicine, 1989
- Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levelsAtherosclerosis, 1989